Seattle, WA – According to filings with the U.S. Securities and Exchange Commission, KitoTech Medical is raising $3,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Ronald Berenson played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About KitoTech Medical
KitoTech Medical was spun out of the University of Washington in 2013 to develop medical products based on its proprietary Microstaple Technology Platform. The Company’s founder, Ronald Berenson, MD, a serial entrepreneur, focused on using this Microstaple technology to develop a novel wound closure product, microMend, that would be an effective alternative to medical staples and sutures.

To learn more about KitoTech Medical, visit http://kitotechmedical.com/

Contact:
Ronald Berenson, Chief Executive Officer
877-420-1502
rberenson@kitotechmedical.com
https://www.linkedin.com/in/ronald-berenson-2b627011/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved